Abstract:Background Gout is generally considered as an acute or chronic inflammatory disease of the joints due to deposition of crystals of monosodium urate (MSU). However, crystals of MSU do not always elicit inflammation in joints, suggesting that the immunological basis is required for the development of gouty arthritis. Although T helper 17 (Th17) and regulatory T cell subsets in CD4 +T cells have been reported to play a key role in autoimmune diseases, their status in peripheral blood of gout patients are rare studied. Objectives Our present study is to explore whether the absolute numbers of peripheral CD4 +T subsets, especially Th17 cells and CD4 +CD25+FOXP3T regulatory (Treg) cells, is abnormal in gout. Methods A total of 72 patients with gout (70 male/2 female) and 41 age-sexual-matched controls were recruited from the Second Hospital of Shanxi Medical University (from March 1 st in 2016 to July 30th in 2017). Of these, 72 patients were categorised as acute gout who had redness, swelling, warmth and pain at the same time (Group1; n=18) or as acute gout without redness and warmth (Group2; n=52). All patients fulfilled 2015 Gout classification criteria developed by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Patients with a history of other autoimmune diseases, nephropathy, cancer, infectious processes, or hematopathy were excluded. The detail medical histories were collected, comprehensive laboratory examinations were performed, and then the differences between the patients and controls were investigated. The concentrations of CD4 +T cell subsets (the absolute numbers of Th1, Th2, Th17 and Treg cells) in peripheral blood were measured by flow cytometry combined with internal standard beads and then the ratios of Th1/Th2 and Th17/Treg were calculated. Results The duration of their disease was 46.73±54.92 (Group1), or 61.54±70.51 (Group2) months. The white blood cells (WBCs) and neutrophils in gout blood were significantly higher than those in controls (P 0.05). Conclusions The increase of peripheral Th2 and Th17 cells led to an imbalance of CD4 +T cell subsets may correlate with gouty inflammation in an undefined way. The elevation of Th2 and Th17 cells may serve as important reference indices for gout attack and a target of gout treatment. Moreover, Th17 may contribute to the persistence of the disease. Reference [1] Zhou Z, Li X, Li H, Guo M, Liu S, Li C. Genetic Analysis of IL-17 Gene Polymorphisms in Gout in a Male Chinese Han Population. PLoS One [Internet]2016;11(2):e0148082. Disclosure of Interest None declared

Advancements in the study of IL-6 and its receptors in the pathogenesis of gout

Immune and inflammatory mechanisms and therapeutic targets of gout: An update

Pathogenesis of gout: Exploring more therapeutic target

IL1A Regulates the Inflammation in Gout Through the Toll-like Receptors Pathway

FRI0239 Absolute numbers of peripheral th17 and th2 cells increased in patients with gout

The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications

Elevated serum IL-2 and Th17/Treg imbalance are associated with gout

Recent Insights Into the Role of Macrophages in Acute Gout

Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions

Research progress of interleukin-1 inhibitors and uricases in the treatment of gout

Spontaneous resolution of acute gout: mechanisms and therapeutic targets

Metabolic Regulation of Immune Response and Tissue Remodeling in Gouty Arthritis (Review).

The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications

Hyperuricemia and its related diseases: mechanisms and advances in therapy

Interleukin 37 Limits Monosodium Urate Crystal-Induced Innate Immune Responses in Human and Murine Models of Gout

Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors

The inflammatory process of gout and its treatment

Nerve modulation therapy in gouty arthritis: targeting increased sFRP2 expression in dorsal root ganglion regulates macrophage polarization and alleviates endothelial damage

Leptin Promotes Monosodium Urate Crystal-Induced Inflammation in Human and Murine Models of Gout

Role of microRNA alternation in the pathogenesis of gouty arthritis